Avelas Biosciences' Series B - II Round

Avelas Biosciences raised a round of funding on September 10, 2014.

Avelas Biosciences is a biotechnology company focused on developing fluorescent technologies that advance a new standard-of-care for cancer surgery. Avelas aims to create better outcomes for cancer pa…

Articles about Avelas Biosciences' Series B - II Round: